CPI Week.
Three Non-Tech Setups.
Week of July 13 — ENSG · MPC · PJT
The June CPI print (July 14) headlines the week. Our watchlist steps off the crowded tech trade — defensive healthcare, momentum energy, and a high-quality advisory bank, each with its own driver and its own read on the Fed.
A make-or-break CPI — as the energy spike fades
Since Chair Warsh's hawkish June debut, futures still imply roughly a two-thirds chance of at least one hike by December; nine of nineteen officials pencil in an increase this year, median dot at 3.8%. Next week's marquee event puts the thesis to the test: June CPI, due July 14 — the biggest data point before the July 28–29 FOMC.
There's a crosscurrent: the energy spike that drove much of the inflation scare — tied to the Iran war and the Strait of Hormuz — has begun to ease as a U.S.–Iran de-escalation is reported and prices slide. So June's still-hot data meets a softening forward picture. A cool print cools the hike bets; a hot one cements them.
After the Magnificent Seven whipsawed through June, we've leaned deliberately into three names outside the tech trade — different sectors, different drivers, different reactions to whatever the CPI print delivers.
Notice how differently they read the same macro: ENSG barely cares what the Fed does, MPC actually benefits from energy inflation even as its supply premium fades, and PJT has a way to profit whether rates loosen the deal market or tighten it into restructuring.
The defensive healthcare compounder
ENSG carries the best annual win rate on the list at 83.33%, matched by an 83.33% frequency and a solid 7.58 profit factor — a consistent, well-balanced profile.
Ensign is a skilled-nursing and senior-living operator run on a decentralized "cluster" model that has made it one of healthcare's best compounders. Q1 was a record: revenue rose 18.4% to $1.39B, adjusted EPS climbed 21.7% to $1.85, and same-store occupancy hit a record 84.3%. Management raised FY guidance to $7.48–$7.62 (~15% growth); 395 operations across 17 states, with the Standard Bearer captive REIT capturing real-estate value.
In June, short-seller Hunterbrook Media alleged systemic understaffing, improper billing, and quality-measure manipulation; the stock fell ~7% and several law firms opened securities investigations. Ensign disputes the characterization — but this belongs at the center of any risk assessment, not a footnote.
Expected Thursday, July 23, 2026 (est.). Q2 EPS consensus ~$1.80 — watch occupancy, skilled mix, and any response to the allegations.
One of the more Fed-insulated names you'll find — demand for post-acute care doesn't hinge on rates. Its real risks are sector-specific (Medicare/Medicaid reimbursement) and, right now, the short-seller and securities-investigation overhang.
Best annual win rate on the list and a record-results, demographically defended business — but a live short-seller report and securities investigations are a genuine overhang. Strong stats, real caution; size the headline risk deliberately.
The refining momentum name
MPC brings the two heaviest numbers on the board: the highest profit factor at 22.99 and the highest annualized return at 97.22%, with an 86.67% frequency. When this window has worked, it has paid enormously.
Marathon is the largest independent U.S. refiner, paired with midstream arm MPLX. Q1 delivered ~$2.8B adjusted EBITDA and ~$1B returned to shareholders on high utilization and robust margins — and the stock has ridden that to a ~74% gain over the past year. A cash-return machine on a favorable refining backdrop.
Refining margins spiked when the Iran war and Strait of Hormuz tightened fuel supply (Europe warned of a jet-fuel shortage). But that premium is now fading: with a U.S.–Iran de-escalation reported and crude easing, crack spreads have come off their mid-May peak. Layer on a political overhang — "gouging" accusations, a DOJ inquiry, an AI-pricing lawsuit — and the tailwind is softening. Targets span $217–$344 (avg ~$271), Buy consensus.
Tuesday, August 4, 2026 (confirmed). Watch Q2 utilization, crack-spread capture, and the pace of buybacks and dividends.
A useful counterweight in a rate-anxious tape: energy is an inflation hedge, so MPC tends to benefit from the very price pressure keeping the Fed hawkish. Swing factors are crack spreads and geopolitics — not the discount rate.
Highest profit factor and annualized return on the list, a cash-returning refiner and energy-inflation hedge. Variables: a fading Iran/Hormuz premium, a political/DOJ overhang, and a valuation up ~74% on the year, into an August 4 print.
The advisory-bank dual engine
PJT posts the highest frequency on the list at 92.31%, with a strong 11.44 profit factor and an 87.3% annualized return — one of the most reliable profiles in the scan.
PJT Partners is an elite independent advisory investment bank led by Paul Taubman, spanning M&A advisory, capital markets, restructuring and special situations, and fund placement. Q1 set records: revenue rose 29% to $418.2M, GAAP pretax income jumped 53%, and the firm carries no funded debt against ~$586M of cash. FY2025 revenue grew 15%, EPS up 36%. A high-quality compounder (GuruFocus score 90/100).
PJT's advisory business benefits from a reviving M&A and IPO market, while its restructuring arm is naturally counter-cyclical — it earns more when corporate stress rises. That makes it one of the more balanced financials to own: a way to win whether deal activity accelerates or credit tightens. The stock recently jumped ~5.5% and pushed just above its ~$169 average target.
Expected Tuesday, July 28, 2026 (est.). Watch advisory vs. restructuring revenue mix and deal-pipeline commentary.
Advisory banks track capital-markets activity, so higher-for-longer rates can slow M&A financing — but PJT's restructuring franchise is a built-in hedge against exactly that. Flags: a rich P/E (~37), some insider selling, and lumpy deal-driven revenue.
Highest frequency on the list and a high-quality advisory franchise with a built-in M&A/restructuring hedge, just breaking above its average target. Watch valuation, insider selling, and deal-flow timing into a late-July print.
The three setups, side by side
| Ticker | Frequency | Profit Factor | Ann. Return | Annual Win % | Catalyst |
|---|---|---|---|---|---|
| ENSGThe Ensign Group | 83.33% | 7.58 | 82.05% | 83.33% | Earnings ~Jul 23 |
| MPCMarathon Petroleum | 86.67% | 22.99 | 97.22% | 78.5% | Earnings Aug 4 |
| PJTPJT Partners | 92.31% | 11.44 | 87.3% | 78.57% | Earnings ~Jul 28 |
The Big Picture
Three setups, three sectors, one idea: step outside the mega-cap-tech trade heading into a make-or-break inflation print.
Notice how differently these three read the same macro. ENSG barely cares what the Fed does; MPC actually benefits from energy inflation even as its supply-shock premium fades; and PJT has a way to profit whether rates loosen the deal market or tighten it into restructuring. Into a week defined by the June CPI print, that's a portfolio built to hold up no matter which way the number breaks — by design, not by accident.
The goal is never to predict the week perfectly. Seasonality gives you the roadmap; the data and earnings calendars give you the catalysts; the macro backdrop tells you which risks to size carefully. From there: watch the price action, respect your stops, and refuse to let emotion decide.
Sign Up to View Full Trade Details →
